NCT06711939 Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV) Status NOT_YET_RECRUITING Phase N/A
NCT06710847 A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06710639 Effects of Cognitive Training on Chemotherapy-Induced Cognitive Impairment in Colon Cancer Patients Undergoing Treatment(Chemobrain) in Oncology Patients With Colon Cancer Undergoing Active Treatment Status NOT_YET_RECRUITING Phase NA
NCT06709144 Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06698289 Preoperative Sarcopenia and Surgical Outcomes in Colorectal Cancer Patients Status COMPLETED Phase N/A
NCT06686576 A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer Status RECRUITING Phase PHASE3
NCT06684223 Analysis of Surgical and Oncologic Outcomes After Complete Mesocolic Excision or Non-complete Mesocolic Excision for Right-Sided Colon Cancer Status COMPLETED Phase N/A
NCT06682793 A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression Status RECRUITING Phase PHASE1/PHASE2
NCT06673329 Brodalumab in the Treatment of Immune-Related Adverse Events Status RECRUITING Phase PHASE1
NCT06665087 CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC Status NOT_YET_RECRUITING Phase PHASE2
NCT06655285 The Impact of Inflammatory Adhesion on the Prognosis of Colon Cancer Patients Status COMPLETED Phase N/A
NCT06653478 Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment Status RECRUITING Phase N/A
NCT06652672 Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma Status RECRUITING Phase NA
NCT06652412 CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC Status NOT_YET_RECRUITING Phase PHASE2
NCT06646445 Neoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon Cancer: PREMICES Study. Status NOT_YET_RECRUITING Phase PHASE2
NCT06640166 Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab. Status RECRUITING Phase PHASE2
NCT06632054 Use of Text Messaging Reminders to Increase FIT Completion Among Patients at the NYU FHCs Status COMPLETED Phase NA
NCT06625515 First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers Status TERMINATED Phase PHASE1
NCT06609551 CtDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: a Single-center, Randomized, Controlled Study Status RECRUITING Phase PHASE3
NCT06580574 Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers Status RECRUITING Phase PHASE2